Learn more about whether Penumbra, Inc. or ResMed Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Penumbra Inc develops and manufactures medical ... This article was generated by Benzinga's automated content engine and reviewed by an editor.
and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other ...
Fintel reports that on January 21, 2025, UBS initiated coverage of Penumbra (NYSE:PEN) with a Buy recommendation. Analyst ...
Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2024 after market close on Tuesday, February 18 ...
Fintel reports that on December 11, 2024, Wells Fargo upgraded their outlook for Penumbra (NYSE:PEN) from Equal-Weight to Overweight. Analyst Price Forecast Suggests 5.31% Downside As of December ...
As of December 23, 2024, the average one-year price target for Penumbra is $264.18/share. The forecasts range from a low of $232.30 to a high of $339.15. The average price target represents a ...